Cutaneous borreliosis associated with T cell–predominant infiltrates: A diagnostic challenge - 14/03/15
, Dmitry V. Kazakov, MD, PhD a, b, Eugen Hübscher, MD c, Oliver Gugerli, MD d, Andreas W. Gerbig, MD e, Regula Schmid, MD f, Gabriele Palmedo, PhD g, Heinz Kutzner, MD gAbstract |
Background |
With the exception of erythema migrans, Borrelia infection of the skin manifests much more commonly with B cell–rich infiltrates. T cell–rich lesions have rarely been described.
Objective |
We report a series of 6 patients with cutaneous borreliosis presenting with T cell–predominant skin infiltrates.
Methods |
We studied the clinicopathologic and molecular features of 6 patients with T cell–rich skin infiltrates.
Results |
Half of the patients had erythematous patchy, partly annular lesions, and the other patients had features of acrodermatitis chronica atrophicans. Histopathology revealed a dense, band-like or diffuse dermal infiltrate. Apart from small, well differentiated lymphocytes, there were medium-sized lymphocytes with slight nuclear atypia and focal epidermotropism. An interstitial histiocytic component was found in 4 cases, including histiocytic pseudorosettes. Fibrosis was present in all cases but varied in severity and distribution. In 5 patients, borrelia DNA was detected in lesional tissue using polymerase chain reaction studies. No monoclonal rearrangement of T-cell receptor gamma genes was found.
Limitations |
This retrospective study was limited by the small number of patients.
Conclusion |
In addition to unusual clinical presentation, cutaneous borreliosis can histopathologically manifest with a T cell–rich infiltrate mimicking cutaneous T-cell lymphoma. Awareness of this clinicopathologic constellation is important to prevent underrecognition of this rare and unusual presentation representing a Borrelia-associated T-cell pseudolymphoma.
Le texte complet de cet article est disponible en PDF.Key words : borreliosis, cutaneous T-cell lymphoma, interstitial granulomatous dermatitis, T cell
Abbreviations used : ACA, CTCL, EM, MF, PDC, PCR, TCR
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
Vol 72 - N° 4
P. 683-689 - avril 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
